Creatine and Depression: What Five Trials Actually Found

What the Review Actually Covered

The 2026 systematic review in the Canadian Journal of Psychiatry gathered every randomised controlled trial of creatine monohydrate in mental disorders it could find^[1]. For depression it came to five trials, reported across six published articles, with 238 participants at baseline: 126 assigned to creatine and 112 to placebo. Mean age was 36 and the majority were women.

Hold that number in mind, because it is the whole story. 238 people is not a large evidence base. A single well-powered antidepressant trial routinely enrols more than that on its own. Five small trials pointing in different directions is what an early-stage research question looks like, not a finding.

The Two Positive Trials

The strongest result comes from Lyoo and colleagues in the American Journal of Psychiatry in 2012^[3]. 52 women with major depressive disorder, all taking the SSRI escitalopram, were randomised to add either creatine or placebo for eight weeks. The creatine group started at 3g a day for a week then moved to 5g a day. Improvement on the Hamilton Depression Rating Scale was significantly greater with creatine, and remission reached 52% against 25.9% on placebo.

The second positive result came from Sherpa and colleagues in 2024, who randomised 100 adults receiving cognitive behavioural therapy to add 5g a day of creatine or placebo, tracking symptoms on the PHQ-9^[7]. The creatine arm improved more.

Now the part that gets dropped in every headline about this research. In both trials creatine was an addition to a treatment that was already running. Escitalopram in one. CBT in the other. Not a single trial in the review tested creatine as a replacement for either. So even on the most generous reading of the positive results, what was tested was creatine plus treatment against treatment alone. There is no evidence whatsoever for creatine instead of treatment, because nobody has studied it.

The Three Trials That Found Nothing

Nemets and Levine ran a four-week dose-finding trial in 18 adults with treatment-resistant depression at 5g or 10g a day and found no significant treatment or dose effect on the Hamilton scale^[1].

Kondo and colleagues randomised 33 adolescent girls with major depression across 2g, 4g and 10g daily doses for eight weeks and found no significant difference against placebo on the Children's Depression Rating Scale, although prefrontal phosphocreatine levels were inversely correlated with depression scores^[1].

A pattern worth noticing: the two positive trials both paired creatine with an active treatment, while the null trials largely did not, or ran in harder-to-treat populations. That is a hypothesis, not a conclusion, and with five trials there is nowhere near enough data to test it.

The Bipolar Safety Signal

Toniolo and colleagues ran a proof-of-concept trial of creatine as an adjunct in bipolar depression, randomising 35 patients, 17 to creatine at 6g a day and 18 to placebo, over six weeks, with 23 completing^[4]. The primary outcome, change on the Montgomery-Asberg scale, was not significant.

The finding that matters is in the adverse events. One patient in the creatine group switched to hypomania at the end of week two, and another in the same group switched to mania at the beginning of week two^[4].

Two events in a 17-person arm is a small number that deserves a large amount of caution. It could be chance. It is also biologically coherent, since agents that lift mood in depression can precipitate a switch in bipolar disorder, which is a well-recognised phenomenon with antidepressants. We are not going to tell you it is proven, and we are not going to tell you to ignore it. If you have bipolar disorder or any history of mania or hypomania, do not start creatine for mood reasons without talking to your psychiatrist first.

Why Creatine Might Affect Mood

The mechanistic argument is genuinely reasonable, which is why the question keeps getting asked. The review notes that depression may involve impaired brain energy metabolism and mitochondrial pathology, and that creatine is stored in the brain as phosphocreatine, which can rapidly replenish ATP when metabolic demand is sustained^[1]. Two of the trials found associations between creatine-linked brain phosphocreatine or N-acetylaspartate changes and symptom improvement.

A plausible mechanism plus a correlation is not causation. Plenty of compounds have an elegant mechanistic story and no clinical effect. The mechanism explains why the question is worth a properly powered trial. It does not substitute for one.

Dose and Form: There Is No "Mood" Creatine

Across all five trials the compound was ordinary creatine monohydrate, dosed between 2g and 10g a day, most commonly at 5g^[1]. No trial used a patented form, a buffered version, a hydrochloride, or anything marketed for mood or cognition.

This matters commercially, because the predictable next step is a premium product positioned around mental wellbeing at several times the price of monohydrate. There is no evidence base for that product. The research was done on the cheapest form of creatine on the shelf, which in Australia typically runs a few cents per daily serve. If a "mood creatine" appears at a premium, it is a marketing position rather than a different molecule.

What Australian Labels Can Legally Claim

Australian advertising rules for therapeutic goods treat serious conditions, meaning those requiring diagnosis or management by a health professional, as restricted or prohibited territory for advertising claims, with restricted representations needing prior approval before use^[6]. Depression sits squarely in that category.

It is also worth restating what an AUST L number means, because it is widely misread. It is the sponsor certifying that a product is low risk and made to standard, not the TGA endorsing an efficacy claim for any condition. A creatine tub with an AUST L number has not been assessed as effective for mood by anyone.

The Verdict

Do not change your treatment because of this research. If you are on an antidepressant or in therapy, keep going. The two trials that found a benefit added creatine on top of exactly that, and no trial has ever tested creatine as a replacement. Stopping effective treatment on the strength of five small studies would be a serious mistake.

If you already take creatine for training, this changes nothing about that. Creatine monohydrate remains one of the best-evidenced and cheapest supplements in sport, and the mood research neither adds to nor subtracts from that case. You do not need to stop, and you should not start expecting a mood effect.

If you have bipolar disorder, treat this as a caution rather than an opportunity. The only bipolar trial found no benefit and recorded two mood switches in the creatine arm.

Talk to your GP before adding any supplement to a mental-health treatment plan. That is not a disclaimer we are adding for form. With an evidence base this thin and a documented interaction risk in one population, a five-minute conversation is genuinely the right call. If you are struggling right now, contact your GP, or call Lifeline on 13 11 14 for 24-hour support in Australia.

As the review's co-author Nicholas Fabiano put it, "We cannot yet reliably say that creatine helps with depressive symptoms or if the findings are generalizable to everyone"^[2]. We would rather report that accurately than sell you a headline^[5].

• Read the 2026 systematic review in full rather than the press coverage of it, and pulled the trial-level detail from its evidence tables.
• Went to the primary papers for the two claims that carry the most weight, the escitalopram augmentation result and the bipolar mood-switch events, rather than relying on the review's summary of them.
• Used the primary trial's participant numbers for the bipolar study where they differed from the review's summary table, and noted the discrepancy rather than quietly picking one.
• Checked whether any positive trial tested creatine as a standalone treatment. None did, which is why the add-on framing appears throughout.
• Left out one confidence interval and one piece of legislative wording we could not verify against a primary source.

Frequently Asked Questions

Cheapest Creatine Monohydrate in AustraliaBrowse all creatine →

OrkuCreatine Monohydrate Powder 200 Mesh Micronised 99.9% Pure

$2.60/100g

OrkuCreatine Monohydrate Powder Tub 200 Mesh Micronised 99.9% Pure

$4.00/100g

VPACreatine Monohydrate

$4.80/100g